Pentax Pharma Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 0.18 M
- Company Age 32 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 8.48 Cr
- Satisfied Charges ₹ 27.04 Cr
- Revenue Growth -5.07%
- Profit Growth 24.64%
- Ebitda -0.84%
- Net Worth 17.69%
- Total Assets 16.82%
About Pentax Pharma
Pentax Pharma Pvt Ltd (PPPL) is a Private Limited Indian Non-Government Company incorporated in India on 07 September 1992 and has a history of 32 years and four months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Media And Publishing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 0.18 M.
The company currently has active open charges totaling ₹8.48 Cr. The company has closed loans amounting to ₹27.04 Cr, as per Ministry of Corporate Affairs (MCA) records.
Pragnyat Lalwani and Gautam Jain serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24139MH1992PTC068429
-
Company No.
068429
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
07 Sep 1992
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Pentax Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pragnyat Lalwani
|
Director | 07-Sep-1993 | Current |
|
Gautam Jain
|
Director | 17-Jan-1994 | Current |
Financial Performance of Pentax Pharma.
Pentax Pharma Pvt Ltd, for the financial year ended 2019, experienced Minor drop in revenue, with a 5.07% decrease. The company also saw a substantial improvement in profitability, with a 24.64% increase in profit. The company's net worth Soared by an impressive increase of 17.69%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pentax Pharma?
In 2019, Pentax Pharma had a promoter holding of 76.92% and a public holding of 23.08%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Prayaas Automation Private LimitedPragnyat Lalwani and Gautam Jain are mutual person
-
Seshaasai Business Forms Pvt LtdPragnyat Lalwani and Gautam Jain are mutual person
-
Dandelion Technologies Private LimitedPragnyat Lalwani and Gautam Jain are mutual person
-
Srichakra Infratech Private LimitedPragnyat Lalwani and Gautam Jain are mutual person
-
Qupod Technovations Private Limited
Pragnyat Lalwani and Gautam Jain are mutual person
-
Seshaasai Datagenie Private Limited
Pragnyat Lalwani and Gautam Jain are mutual person
Charges (Loans)
₹84.80 M
₹270.36 M
Charges Breakdown by Lending Institutions
- State Bank Of India : 8.48 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 May 2019 | State Bank Of India | ₹8.48 Cr | Open |
| 08 Dec 2016 | Axis Bank Limited | ₹7.00 Cr | Satisfied |
| 11 Dec 2013 | The Greater Bombay Co-Op Bank Ltd | ₹1.58 Cr | Satisfied |
| 11 Dec 2013 | The Greater Bombay Co-Op Bank Ltd | ₹1.94 Cr | Satisfied |
| 17 Dec 2007 | The Greater Bombay Co-Operative Bank Ltd | ₹14.27 Cr | Satisfied |
How Many Employees Work at Pentax Pharma?
Unlock and access historical data on people associated with Pentax Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pentax Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pentax Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.